Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft-<i>versus</i>-host disease. | Haematologica;108(2): 301-302, 2023 02 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft-versus-host disease.

Pidala, Joseph; Anasetti, Claudio.

Affiliation

Pidala J; Blood and Marrow Transplantation and Cellular Immunotherapy H. Lee Moffitt Cancer Center and Research Institute Tampa, FL. Joseph.Pidala@moffitt.org.
Anasetti C; Blood and Marrow Transplantation and Cellular Immunotherapy H. Lee Moffitt Cancer Center and Research Institute Tampa, FL.

Haematologica ; 108(2): 301-302, 2023 02 01.

Article in En | MEDLINE | ID: mdl-35546302

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia / Graft vs Host Disease Limits: Humans Language: En Journal: Haematologica Year: 2023 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia / Graft vs Host Disease Limits: Humans Language: En Journal: Haematologica Year: 2023 Document type: Article